文章摘要
韩泽平,麦正均,黎毓光,等.羽扇豆醇联合槲皮素对膀胱癌 5637细胞的抑制作用[J].安徽医药,2021,25(5):854-858.
羽扇豆醇联合槲皮素对膀胱癌 5637细胞的抑制作用
Inhibitory effect of lupeol and quercetin on bladder cancer 5637 cells
  
DOI:10.3969/j.issn.1009-6469.2021.05.002
中文关键词: 五环三萜类  黄酮类  羽扇豆醇  槲皮素  联合作用  膀胱癌  miR-145
英文关键词: Pentacyclic triterpenes  Flavones  Lupeol  Quercetin  Combined effect  Bladder cancer  MiR-145
基金项目:广东省中医药局面上项目(20192073);广州市卫生健康委员会中医药和中西医结合科技项目(20192A011027;20212A010025);广州市番禺区科技计划项目(2020-Z04-026)。
作者单位E-mail
韩泽平 广州市番禺区中心医院检验科广东广州 511400  
麦正均 广州市番禺区中心医院检验科广东广州 511400  
黎毓光 广州市番禺区中心医院检验科广东广州 511400  
吕钰冰 广州市番禺区中心医院检验科广东广州 511400  
何思华 广州市番禺区中心医院检验科广东广州 511400  
周嘉彬 广州市番禺区中心医院检验科广东广州 511400  
何金花 广州市番禺区中心医院检验科广东广州 511400 332518579@qq.com 
摘要点击次数: 1692
全文下载次数: 445
中文摘要:
      目的研究羽扇豆醇(Lupeol)联合槲皮素(Quercetin)对膀胱癌 5637细胞增殖抑制的作用,为膀胱癌的治疗提供实验依据。方法利用噻唑蓝(MTT)法分别检测不同浓度的羽扇豆醇(10、20、40、60、80、100、120 μmol/L)及槲皮素(5、10、20、40、 60、80 μmol/L)对膀胱癌 5637细胞的增殖抑制作用,并计算作用 48 h后细胞的生长抑制率。选取抑制率为 30%的药物浓度(即 IC30)作为加药浓度分别单独及联合处理 5637细胞 48 h,MTT法检测各处理组细胞生长抑制率,并计算两种药物多个组合的 Q值,以评价联合效果。利用克隆形成实验及划痕实验检测细胞克隆能力及迁移能力的影响。利用实时荧光定量反转录 PCR(qRT-PCR)检测 miR-145的表达水平。结果羽扇豆醇和槲皮素均能有效抑制膀胱癌细胞的增殖,呈浓度依赖性,槲皮素的量效变化更为明显。计算得出羽扇豆醇和槲皮素 48 h的 IC50分别为 50.02 μmol/L和 44.42 μmol/L;IC30分别为 35.40 μmol/L(实验中使用 35 μmol/L)和 29.86 μmol/L(实验中使用 30 μmol/L),羽扇豆醇与槲皮素联合作用 5637细胞抑制率达 58.83%,两种药物为协同作用(Q值为 1.167)。两种药物联合作用可明显抑制 5637细胞的克隆形成及迁移能力,并使 miR-145相对表达量增高。结论羽扇豆醇和槲皮素均能抑制膀胱癌 5637细胞生长,并呈浓度依赖性,两种药物联合能协同抑制细胞的增殖,并明显抑制其克隆形成能力及迁移能力,其分子机制可能与 miR-145的表达增高相关。
英文摘要:
      Objective To study the effects of Lupeol combined with quercetin on the proliferation inhibition of bladder cancer 5637cells, and to provide experimental evidence for the treatment of bladder cancer.Methods The MTT method was used to detect different concentrations of lupeol (10, 20, 40, 60, 80, 100, 120 μmol/L) and quercetin (5, 10, 20, 40, 60, 80 μmol/L) Inhibiting the proliferation of bladder cancer 5637 cells, and calculating the growth inhibition rate of the cells after 48 h. The drug concentration with the inhibition rate of 30% (IC30) was selected as the dosing concentration to treat 5637 cells individually and in combination for 48 h. The MTTmethod was used to detect the cell growth inhibition rate of each treatment group, and the Q value of multiple combinations of the twodrugs was calculated and evaluated the joint effect. The effects of cell cloning ability and migration ability were detected by clone formation experiment and scratch experiment. The expression level of mir-145 was detected by real-time fluorescence quantitative reverse transcription PCR (qRT-PCR).Results Both lupeol and quercetin can effectively inhibit the proliferation of bladder cancer cells in a concentration-dependent manner, and the dose-effect change of quercetin was more obvious. The IC50 of lupeol and quercetin at 48 h was 50.02 μmol/L and 44.42 μmol/L respectively. The IC30 of lupeoland quercetin were 35.40 μmol/L (35 μmol/L in the experiment)and 29.86 μmol/L (30 μmol/L in the experiment) respectively. The inhibition rate of 5637 cells under the combined treatment of lupeoland quercetin was 58.83%, and the two drugs had a synergistic effect (Q value was 1.167). The combination of the two drugs could significantly inhibit the cloning and migration ability of 5637 cells, and increase the relative expression of miR-145.Conclusions Both lupeol and quercetin could inhibit the growth of bladder cancer 5637 cells in a concentration-dependent manner. The combination ofthe two drugs could synergistically inhibit the cell proliferation, and significantly inhibit cell cloning and migration ability. The molecular mechanism might be related to the increased expression of miR-145.
查看全文   查看/发表评论  下载PDF阅读器
关闭

分享按钮